Revenue Slightly Missed Expectations, but Long-Term Order and Localization Thesis Remains Intact; Reiterate Outperform

Overview

AMEC disclosed its first-half 2026 earnings preview on August 3, 2026. Bernstein believes the performance was mixed: second-quarter revenue was slightly below its forecast and consensus expectations, while net profit attributable to shareholders increased sharply but was mainly contributed by investment income. Excluding investment income, recurring net margin remained solid. Weak near-term market sentiment may pressure the share price, but the report judges this could be the last meaningful pullback before important catalysts emerge, and reiterates its Outperform rating.

Core views

First, revenue was slightly below expectations, but still maintained relatively rapid year-over-year growth. Second, the high growth in reported net profit mainly came from non-recurring investment income, so operating quality should be assessed by focusing on non-recurring-item-adjusted profit and recurring net margin. Third, with the R&D expense ratio as high as 30%, recurring net margin still reached 16.5%, showing strong earnings potential in the core business; if R&D intensity declines in the future, net margin is expected to improve. Fourth, investment in new products such as thin-film deposition over the past several years is beginning to enter the monetization phase, and new product development cycles have shortened to within two years. Fifth, growth in China wafer fabrication equipment demand, increasing localization share, and a potential catalyst from YMTC’s IPO prospectus could drive 2027-2028 earnings significantly above market expectations.

Analysis framework

The report uses a combination of earnings preview breakdown, comparison with consensus expectations, recurring profit adjustment, scenario analysis of R&D intensity and potential margin, order and industry demand outlook, and P/E valuation. The analysis focuses on distinguishing investment income from core operating profit, and assesses medium-term growth based on China’s wafer fabrication equipment cycle, domestic substitution progress, and customer capacity expansion expectations.

Methodology notes

• Earnings AnalysisActual Results vs. Expectations

  Compare revenue, net profit, and net margin with institutional forecasts and consensus expectations respectively.

  Second-quarter revenue was about 3% below consensus expectations; recurring net margin was above Bernstein’s forecast but below consensus expectations, so overall results were judged to be mixed.

• Earnings Quality AnalysisNon-Recurring Gains and Losses Adjustment

  Observe recurring net profit attributable to shareholders and net margin after excluding investment income.

  The sharp increase in reported net profit attributable to shareholders was mainly contributed by investment income; excluding this factor better reflects the profitability of the core business.

• Scenario AnalysisNormalization of R&D Expense Ratio

  Estimate the potential margin when R&D intensity declines from the current high level toward the global industry average.

  The report believes that the company still achieved a recurring net margin of 16.5% when the R&D expense ratio was about 30%; if the R&D expense ratio normalizes toward the global average of about 15% in the future, net margin could approach 30%, but this result is a scenario analysis rather than realized guidance.

• Valuation methodsForward P/E Valuation

  Calculate the target price by multiplying 2027 forecast EPS by the target P/E multiple.

  Bernstein uses 2027 forecast EPS of RMB 7.18 and a 70x P/E multiple, corresponding to a target price of CNY 500.00.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• AMEC (688012.CH)

  Core covered stock, benefiting from growth in China wafer fabrication equipment demand and domestic substitution.

  Strengths

  Strong potential for order growth; etching equipment has a competitive foundation; investment in thin-film deposition is expected to enter the harvest phase; recurring net margin remains solid despite high R&D intensity.

  Weaknesses

  Second-quarter revenue was below expectations; reported net profit relies heavily on investment income; high R&D investment suppresses margins in the short term; the MOCVD business faces pressure from weak demand.

  Comparison

  Consensus expectations only forecast 36% year-over-year revenue growth in 2027, while Bernstein judges that growth could exceed 70% based on current orders; the 16.5% recurring net margin is above the institution’s forecast but below consensus expectations.

  Risks

  Capital expenditure by Chinese wafer fabs falling short of expectations, a larger-than-expected decline in MOCVD revenue, technical breakthroughs by domestic equipment makers or capacity expansion progressing more slowly than expected, and volatility risk from high valuation.

Key data

• Second-quarter 2026 revenueRMB 3.78 billionUp 35.5% year over year and about 3% below consensus expectations.
• Second-quarter 2026 net profit attributable to shareholdersRMB 1.87 billionUp 375.9% year over year, mainly driven by investment income in the first half.
• First-half 2026 investment incomeRMB 1.98 billionThe main source of the sharp increase in reported net profit attributable to shareholders.
• Recurring net profit attributable to shareholdersRMB 1.0 billion to RMB 1.2 billionExcluding the impact of investment income, up 85.6% to 122.7% year over year.
• Recurring net margin16.5%Above Bernstein’s forecast of 15.7% and below consensus expectations of 18.6%.
• Second-quarter 2026 R&D investmentRMB 1.13 billionAbout 69% of which was expensed, with an R&D expense ratio of about 30%.
• Gap in 2027 revenue growth expectationsBernstein believes it could exceed 70%; consensus expectation is 36%The institution’s view is based on the company’s orders for the year, supported by the upcycle in China wafer fabrication equipment and increasing localization share.
• Target priceCNY 500.00Based on 2027 forecast EPS of RMB 7.18 and a 70x P/E multiple.
• Closing price and potential upsideCNY 309.85; 61%The closing date was August 3, 2026.
• Forecast EPSRMB 3.40 in 2025; RMB 4.95 in 2026; RMB 7.18 in 20272025 is the actual value, while 2026 and 2027 are forecast values.

Impact & implications

In the short term, revenue falling short of expectations, a profit structure skewed toward investment income, and weak overall market sentiment may trigger a negative share price reaction. In the medium to long term, high R&D investment is shortening new product development cycles and strengthening the pipeline for businesses such as thin-film deposition; if capital expenditure by Chinese wafer fabs recovers, YMTC-related information releases positive signals, and the localization share of domestic equipment continues to rise, the company’s orders, revenue, and earnings may significantly exceed current market expectations. Future normalization of the R&D expense ratio may also become an important source of net margin expansion.

Risks

• Weak LED equipment demand leads to a greater-than-expected decline in MOCVD revenue.
• Capital expenditure by Chinese wafer fabs fails to reach expected targets, weakening semiconductor equipment order growth.
• Technical difficulties in specific manufacturing steps or production capacity bottlenecks at domestic equipment manufacturers cause the localization process to be slower than expected.
• Investment income is non-recurring, and reported net profit may overstate the sustainable profitability of the core business.
• If the R&D expense ratio remains high for an extended period, the expected improvement in net margin may be delayed.
• The 70x target P/E based on 2027 earnings is relatively high, and earnings or order realization below expectations may trigger a valuation pullback.

What to watch

• YMTC’s potential IPO prospectus in the coming months and the capital expenditure, capacity, and equipment procurement plans disclosed therein.
• Whether the company’s backlog and new orders can support the judgment that 2027 revenue growth will exceed 70%.
• The business cycle of China’s wafer fabrication equipment market and realization of capital expenditure by major wafer fabs.
• Localization share, new product validation, and revenue ramp-up progress for etching equipment and thin-film deposition equipment.
• Whether the R&D expense ratio starts to decline from 2027, and the impact of changes in the expensing ratio on net margin.
• Trends in recurring profit, gross margin, and net margin after excluding investment income.
• MOCVD business revenue and changes in LED equipment demand.